Prevalence of Lynch syndrome in unselected patients with endometrial or ovarian cancer. - PubMed - NCBI

Prevalence of Lynch syndrome in unselected patients with endometrial or ovarian cancer. - PubMed - NCBI

Arch Gynecol Obstet. 2016 Nov;294(6):1299-1303. Epub 2016 Aug 18.

Prevalence of Lynch syndrome in unselected patients with endometrial or ovarian cancer.

Kast K1,2,3, Dobberschütz C4,5,6, Sadowski CE4,5,6, Pistorius S7,8, Wimberger P4,5,6.

Author information

Abstract

INTRODUCTION:

Lynch syndrome is known by healthcare providers mainly for patients with colorectal cancer. Awareness of other associated tumors, such as endometrial or ovarian cancer, is low. This study aimed to analyze the prevalence of Lynch syndrome in unselected patients with endometrial or ovarian cancer. In addition, the willingness of patients and family members to undergo germline mutation testing was investigated.

METHODS:

The medical records of all patients diagnosed with endometrial or ovarian cancer at the Department of Gynecology and Obsterics, University Hospital Dresden, between 1998 and 2012, were screened for a family history of HNPCC-associated cancer. Telephone interviews were used to screen, inform, and enroll patients in this genetic analysis study. Molecular analysis was performed by prescreening of tumor tissue, followed by germline mutation analysis.

RESULTS:

Two hundred and eighty-three patients were diagnosed with endometrial cancer, 291 with ovarian cancer, and 14 with both. A positive family history for tumors associated with Lynch syndrome was documented for 61 patients. Two pathogenic mutations in the genes MLH1 and MSH2 in nine genetic analyses had already been detected before. After genetic counseling, only 10 of 31 index patients (32.3 %) consented for mutation analysis. However, no additional pathogenic heterozygous mutations were found.

CONCLUSION:

In this retrospective cohort study in unselected patients with endometrial or ovarian cancer, only a small number of patients with suspected Lynch syndrome could be identified. Of those, acceptance of germline analyses was moderate, only. As a result, the rate of identified pathogenic germline mutations was lower than expected. Therefore, we are convinced that more information on cancer risks, options for predictive molecular testing and preventive procedures, needs to be provided to patients and gynecologists.

KEYWORDS:

Hereditary endometrial cancer; Lynch syndrome; Ovarian cancer

PMID:

 

27535758

 

DOI:

 

10.1007/s00404-016-4180-0

[PubMed - in process]

Public Health Genomics Knowledge Base (v1.2)

LYNCH SYNDROME

Last Updated: Oct 27, 2016

• NICE recommends all bowel cancer patients to be tested for Lynch Syndrome
  Bowel Cancer UK, October 22, 2016
• Prevalence of Lynch syndrome in unselected patients with endometrial or ovarian cancer.
  Kast Karin, et al. Archives of gynecology and obstetrics 2016 11 (6) 1299-1303
• NICE recommends wider use of tests to detect cancer-causing genetic condition
  NICE, United Kingdom, Draft Guidance, October 21, 2016
• Educational and Psychosocial Support Needs in Lynch Syndrome: Implementation and Assessment of an Educational Workshop and Support Group.
  Corines Marina J et al. Journal of genetic counseling 2016 Oct
• Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
  Graffeo Rossella et al. Breast cancer research and treatment 2016 Oct
• Implementing Public Health Genomics in Your State: Resources from the CDC Office of Public Health Genomics
  Disease: Lynch syndrome|Breast Cancer|Ovarian Cancer; Type: Education; State: Multiple States
• Universal tumor screening for Lynch syndrome: health-care providers' perspectives.
  Bombard Yvonne et al. Genetics in medicine : official journal of the American College of Medical Genetics 2016 Oct
• Evaluation of a Population Based Approach to Familial Colorectal Cancer.
  Parfrey P S, et al. Clinical genetics 2016 10
• Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer.
  Chen Yanni et al. Familial cancer 2016 Sep
• Genetic screening in young women diagnosed with endometrial cancer.
  Pecorino Basilio et al. Journal of gynecologic oncology 2016 Sep e4
• Endometrial carcinoma-related genetic factors: application to research and clinical practice in China.
  Zhou J Y et al. BJOG : an international journal of obstetrics and gynaecology 2016 Sep 123 Suppl 390-6
• MLH1 Ile219Val Polymorphism in Argentinean Families with Suspected Lynch Syndrome.
  Dominguez-Valentin Mev, et al. Frontiers in oncology 2016 0 189
• Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
  Lagerstedt-Robinson Kristina, et al. Oncology reports 2016 9
• Facing my fear: did I have the cancer mutation that killed my dad? 
  JH Edelestein, The Guardian, September 9, 2016
• Performance of Lynch syndrome predictive models in quantifying the likelihood of germline mutations in patients with abnormal MLH1 immunoexpression.
  Cabreira Verónica, et al. Familial cancer 2016 8

• CDC Information (3)
• CDC-Authored Pub (9)

• Human (59)
• Pathogen (0)

• Human (296)
• Pathogen (0)

• Human (132)
• Pathogen (0)

• Guidelines (17)
• Tier Table (11)
• Synthesis (30)

• Huamn (76)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB